Soileau MJ, Aldred J, Budur K, Fisseha N, et al. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol 2022;21:1099-1109.
PMID: 36402160